These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36562254)

  • 1. Impaired adaptive immune response in COVID-19 convalescent patients with hematological malignancies.
    Kalicińska E; Szymczak D; Andrasiak I; Milanowska A; Kiraga A; Majeranowski A; Jabłonowska P; Rybka J; Maciej Z; Wróbel T
    Eur J Haematol; 2023 Apr; 110(4):396-406. PubMed ID: 36562254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of IFNγ-Secreting CD4
    Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogenous CD8+ T Cell Maturation and 'Polarization' in Acute and Convalescent COVID-19 Patients.
    Kudryavtsev IV; Arsentieva NA; Korobova ZR; Isakov DV; Rubinstein AA; Batsunov OK; Khamitova IV; Kuznetsova RN; Savin TV; Akisheva TV; Stanevich OV; Lebedeva AA; Vorobyov EA; Vorobyova SV; Kulikov AN; Sharapova MA; Pevtsov DE; Totolian AA
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study.
    Kalicińska E; Szymczak D; Andrasiak I; Bogucka-Fedorczuk A; Zińczuk A; Szymański W; Biernat M; Rymko M; Semeńczuk G; Jabłonowska P; Rybka J; Simon K; Wróbel T
    Transl Oncol; 2021 Jan; 14(1):100943. PubMed ID: 33204385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection.
    Wiech M; Chroscicki P; Swatler J; Stepnik D; De Biasi S; Hampel M; Brewinska-Olchowik M; Maliszewska A; Sklinda K; Durlik M; Wierzba W; Cossarizza A; Piwocka K
    Front Immunol; 2022; 13():886431. PubMed ID: 35757700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
    Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; Jiménez P; Garrido F; Anderson P; Ruiz-Cabello F; López-Ruz MÁ
    Front Immunol; 2020; 11():596553. PubMed ID: 33324414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.
    Christensen EE; Jørgensen MJ; Nore KG; Dahl TB; Yang K; Ranheim T; Huse C; Lind A; Nur S; Stiksrud B; Jenum S; Tonby K; Holter JC; Holten AR; Halvorsen B; Dyrhol-Riise AM
    J Intern Med; 2021 Sep; 290(3):677-692. PubMed ID: 34080738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte Phenotyping and HLA-DR Expression over the Course of COVID-19 Infection in Patients with Different Disease Severity.
    Asmaa-Nafady ; Alaa-Rashad ; Nafady-Hego H; Nasif KA; Ebtessam-Elgezawy ; Elrahman NA; Osman HA
    Clin Lab; 2022 May; 68(5):. PubMed ID: 35536080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study.
    Kalicińska E; Szymczak D; Zińczuk A; Adamik B; Smiechowicz J; Skalec T; Nowicka-Suszko D; Biernat M; Bogucka-Fedorczuk A; Rybka J; Martuszewski A; Gozdzik W; Simon K; Wróbel T
    Cells; 2021 May; 10(6):. PubMed ID: 34071149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of changes in immune status linked to COVID-19 convalescent and its clinical severity in patients and uninfected exposed relatives.
    Torres Rives B; Zúñiga Rosales Y; Mataran Valdés M; Roblejo Balbuena H; Martínez Téllez G; Rodríguez Pérez J; Caridad Marín Padrón L; Rodríguez Pelier C; Sotomayor Lugo F; Valdés Zayas A; Carmenate Portilla T; Sánchez Ramírez B; Carlos Silva Aycaguer L; Portal Miranda JA; Marcheco Teruel B
    Immunobiology; 2022 May; 227(3):152216. PubMed ID: 35436751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Cells Profiles In The Peripheral Blood Of Patients With Moderate To Severe COVID-19 And Healthy Subjects With and Without Vaccination With The Pfizer-BioNTech mRNA Vaccine.
    Al-Attiyah R; Safar HA; Botras L; Botras M; Al-Kandari F; Chehadeh W; Mustafa AS
    Front Immunol; 2022; 13():851765. PubMed ID: 35898494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies.
    Sciacchitano S; De Vitis C; D'Ascanio M; Giovagnoli S; De Dominicis C; Laghi A; Anibaldi P; Petrucca A; Salerno G; Santino I; Amodeo R; Simmaco M; Napoli C; Tafuri A; Di Napoli A; Sacconi A; Salvati V; Ciliberto G; Fanciulli M; Piaggio G; de Latouliere L; Ricci A; Mancini R
    J Transl Med; 2021 Apr; 19(1):139. PubMed ID: 33794925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological imprint of COVID-19 on human peripheral blood leukocyte populations.
    Kratzer B; Trapin D; Ettel P; Körmöczi U; Rottal A; Tuppy F; Feichter M; Gattinger P; Borochova K; Dorofeeva Y; Tulaeva I; Weber M; Grabmeier-Pfistershammer K; Tauber PA; Gerdov M; Mühl B; Perkmann T; Fae I; Wenda S; Führer H; Henning R; Valenta R; Pickl WF
    Allergy; 2021 Mar; 76(3):751-765. PubMed ID: 33128792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive immunity to SARS-CoV-2 infection: A systematic review.
    Silva MJA; Ribeiro LR; Lima KVB; Lima LNGC
    Front Immunol; 2022; 13():1001198. PubMed ID: 36300105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive immune responses during Shigella dysenteriae type 1 infection: an in vitro stimulation with 57 kDa major antigenic OMP in the presence of anti-CD3 antibody.
    Bagchi AK; Sinha AK; Adhikari R; Mukherjee J
    Mol Cell Biochem; 2010 May; 338(1-2):1-10. PubMed ID: 19915959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphocyte populations and subpopulations in peripheral blood of pregnant women with pre-eclampsia].
    Dimitrakova-Dzhambazova E; Milchev N; Pavlov P; Dimitrakov D
    Akush Ginekol (Sofiia); 2005; 44(1):40-4. PubMed ID: 15853011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Profile in Patients With COVID-19: Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome.
    Bobcakova A; Petriskova J; Vysehradsky R; Kocan I; Kapustova L; Barnova M; Diamant Z; Jesenak M
    Front Cell Infect Microbiol; 2021; 11():646688. PubMed ID: 33937096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific features of T- and NK-cellular immunity in chronic lymphocytic leukemia.
    Pochtar EV; Lugovskaya SA; Naumova EV; Dmitrieva EA; Kostin AI; Dolgov VV
    Klin Lab Diagn; 2021 Jun; 66(6):345-352. PubMed ID: 34105910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant activation of CD8+ T-cell and CD8+ T-cell subsets in patients with newly diagnosed IDDM.
    Hehmke B; Michaelis D; Gens E; Laube F; Kohnert KD
    Diabetes; 1995 Dec; 44(12):1414-9. PubMed ID: 7589848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.